Research into Ovarian Cancer

Research into ovarian cancer focuses on testing the efficacy of new diagnostic methods, new surgical procedures, and new pharmacological treatments.  

Numerous targeted treatments for ovarian cancer are currently being evaluated through clinical trials. Clinical trials are necessary to objectively evaluate and monitor the activity of these new drugs.   

The great majority of ovarian cancer clinical trials evaluate the role of immunotherapy in combination with other drugs, a treatment that has been effective for other types of cancer and which has shown promising results in ovarian cancer. Immunotherapy is the use of drugs to stimulate the patient's own immune system to recognise and destroy tumour cells more effectively. 

Clinical trials are also underway with new drugs that act on specific therapeutic targets. These have been discovered thanks to our understanding of how tumour cells work.  

In addition, thanks to the development of liquid biopsies, which look at tumour DNA in the circulation and allow the genetic material of the tumour in the patient's blood to be analysed, studies are being carried out to detect changes in tumour biology. This makes it possible to determine when a patient is resistant to a new therapy and it becomes beneficial to change it.